|
|
BTG Plc - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for BTG Plc. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
BTG Plc. The Group's principal activity developing and commercialising life science technologies. The Group in-licenses, develops and commercialises pharmaceuticals and has a broad pipeline of development programme targeting neurological and other disorders including varicose veins. It acquires the rights to early-stage pharmaceuticals and other medical technologies from a global network of corporations, universities and research institutions. The drug development programme are in the field of oncology, ageing, neuroscience and drug repositioning. The Group's products are Varisolve, Misopess, Benefix, Campath, Infecton, Juvidex and Symadex.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|